PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
CD14 9,941 Target Target Endotoxin receptor 115 80 0.07 -0.55 0.70 0.74
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
CCL14 34 Target Target CCL8 197 6 0.07 -0.89 0.18 0.81
CCL5 2,002 Target Target CXCL11 526 75 0.07 -0.91 0.14 0.79
C5a 4,164 Target Target C4A 1,177 161 0.07 -0.91 0.14 0.78
Epidermal Growth Factor Receptor 24,772 Target Target Erbb2 4,536 770 0.07 -0.90 0.17 0.74
CCL3 1,427 Target Target CCL8 197 38 0.07 -0.89 0.19 0.78
CCL5 2,002 Target Target CCL8 197 45 0.07 -0.87 0.23 0.78
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
CCL3 1,427 Target Target CCL1 220 39 0.07 -0.89 0.18 0.78
CCL7 274 Target Target CCL1 220 17 0.07 -0.93 0.08 0.82
CNTF 1,613 Target Target BDNF 11,163 292 0.07 -0.89 0.18 0.75
CNTF 1,613 Target Target Cardiotrophin-1 351 51 0.07 -0.91 0.15 0.78
Alpha-Glucosidase 4,319 Target Target Alpha-Amylase 7,171 376 0.07 -0.93 0.09 0.77
BD2 76 Target Target BD4 26 3 0.07 -0.92 0.12 0.82
EPHA4 357 Target Target EPHB2 385 25 0.07 -0.93 0.07 0.82
CAMK2A 42 Target Target CAMK2B 21 2 0.07 -0.93 0.10 0.83
EPHA4 357 Target Target EPHA2 532 29 0.07 -0.93 0.08 0.81
CCL4 5,638 Target Target CCL2 3,560 295 0.07 -0.93 0.08 0.78
ACRP30 102 Target Target Adiponectin 11,994 72 0.07 -0.54 0.71 0.73
APOE 12,771 Target Target APOC1 126 82 0.06 -0.59 0.65 0.73
EGF 27,487 Target Target bFGF 9,327 1,029 0.06 -0.93 0.11 0.74
EPHA4 357 Target Target EPHB1 137 14 0.06 -0.93 0.10 0.81
CCL7 274 Target Target CXCL10 2,386 51 0.06 -0.89 0.19 0.77
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
CCL7 274 Target Target CCL14 34 6 0.06 -0.90 0.18 0.80
CCL2 3,560 Target Target CCL1 220 55 0.06 -0.86 0.25 0.76
CXCL10 2,386 Target Target CXCL2 750 83 0.06 -0.93 0.11 0.78
CD14 9,941 Target Target CD34 24,598 970 0.06 -0.93 0.10 0.74
EPHB4 329 Target Target EPHB1 137 13 0.06 -0.93 0.09 0.81
CEA 17,022 Target Target CA 72-4 184 108 0.06 -0.64 0.59 0.72
Beta-Glucosidase 4,297 Target Target Alpha-Glucosidase 4,319 261 0.06 -0.94 0.06 0.78
CCL5 2,002 Target Target CXCL2 750 73 0.06 -0.93 0.10 0.78
CEA 17,022 Target Target AFP 9,751 765 0.06 -0.94 0.08 0.75
CXCL3 145 Target Target CCL8 197 10 0.06 -0.94 0.07 0.82
CXCL7 76 Target Target CCL14 34 3 0.06 -0.94 0.09 0.82
CCL2 3,560 Target Target CXCL10/IP-10 114 37 0.06 -0.82 0.32 0.75
CCL19 658 Target Target ELC 355 28 0.06 -0.94 0.08 0.80
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CXCL7 76 Target Target CCL8 197 7 0.06 -0.94 0.09 0.81
CCL5 2,002 Target Target CXCL10/IP-10 114 27 0.06 -0.87 0.24 0.76
EPHB3 118 Target Target EPHA3 140 7 0.05 -0.95 0.06 0.82
CXCL7 76 Target Target CXCL2 750 13 0.05 -0.90 0.17 0.78
Epidermal Growth Factor Receptor 24,772 Target Target ERBB3 1,154 289 0.05 -0.86 0.25 0.72
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79